Articles From: Celebrity Cruises Steps Up To The Plate As Official Cruise Line Of The Boston Red Sox to Cell Therapeutics to Report Fourth Quarter and Full Year 2012 Financial Results After Market on February 28, 2013


2013/4/29
Modern luxury line partners with Boston Red Sox for 2013 Season BOSTON , April 29, 2013 /PRNewswire/ -- Celebrity Cruises and the Boston Red Sox have announced a comprehensive marketing agreement highlighting the brands' shared commitment to premium experiences and entertainment.
Sign-up for Celebrity Cruises Steps Up To The Plate As Official Cruise Line Of The Boston Red Sox investment picks
2013/5/8
One of the industry's largest Xbox experiences at sea to be featured onboard Celebrity's sleek, luxurious ships MIAMI , May 8, 2013 /PRNewswire/ -- Revealing an addition to its series of premium collaborations, Celebrity Cruises has joined forces with Microsoft's Xbox to integrate the leading destination of video game entertainment into guests' modern luxury vacations.
Sign-up for Celebrity Cruises Unveils Innovative Alliance With Ultimate Entertainment Brand Xbox investment picks
2013/2/7
TORONTO , Feb.
Sign-up for Celestica announces 2013 annual general shareholders' meeting investment picks
2013/4/23
Celestica announces election of directors Canada NewsWire TORONTO , April 23, 2013 /CNW/ - Celestica Inc. (NYSE, TSX: CLS), today announced, in accordance with the requirements of the Toronto Stock Exchange, that the nominees listed in its management information circular were elected as directors of the company at its Annual General Meeting of Shareholders held earlier today.
Sign-up for Celestica announces election of directors investment picks
2013/4/23
TORONTO , April 23, 2013 /PRNewswire/ - Celestica Inc. (NYSE, TSX: CLS), today announced, in accordance with the requirements of the Toronto Stock Exchange, that the nominees listed in its management information circular were elected as directors of the company at its Annual General Meeting of Shareholders held earlier today.
Sign-up for Celestica announces election of directors investment picks
2013/4/23
Celestica announces first quarter financial results Canada NewsWire (All amounts in U.S. dollars.
Sign-up for Celestica announces first quarter financial results investment picks
2013/4/23
(All amounts in U.S. dollars.
Sign-up for Celestica announces first quarter financial results investment picks
2013/3/15
Celestica files Form 20-F Canada NewsWire TORONTO , March 15, 2013 /CNW/ - Celestica Inc. (NYSE: CLS) (TSX: CLS) , a global leader in the delivery of end-to-end product lifecycle solutions, today announced that its annual report on Form 20-F for the year ended December 31, 2012 has been filed with the United States Securities and Exchange Commission.
Sign-up for Celestica files Form 20-F investment picks
2013/3/15
TORONTO , March 15, 2013 /PRNewswire/ - Celestica Inc. (NYSE: CLS) (TSX: CLS) , a global leader in the delivery of end-to-end product lifecycle solutions, today announced that its annual report on Form 20-F for the year ended December 31, 2012 has been filed with the United States Securities and Exchange Commission.
Sign-up for Celestica files Form 20-F investment picks
2013/5/2
TORONTO , May 2, 2013 /PRNewswire/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, is pleased to announce that its Oradea, Romania facility is now certified to ISO 13485.
Sign-up for Celestica Now Certified to ISO 13485 for Medical Device Manufacturing in Romania investment picks
2013/5/2
Celestica Now Certified to ISO 13485 for Medical Device Manufacturing in Romania Canada NewsWire TORONTO , May 2, 2013 /CNW/ - Celestica Inc. (NYSE, TSX: CLS), a global leader in the delivery of end-to-end product lifecycle solutions, is pleased to announce that its Oradea, Romania facility is now certified to ISO 13485.
Sign-up for Celestica Now Certified to ISO 13485 for Medical Device Manufacturing in Romania investment picks
2013/3/25
Celestica Receives Frost & Sullivan's 2012 Global EMS Aerospace and Defense Company of the Year Award Canada NewsWire TORONTO , March 25, 2013 /CNW/ - Celestica Inc. (NYSE: CLS) (TSX: CLS) , a global leader in the delivery of end-to-end product lifecycle solutions, today announced it has received Frost & Sullivan's 2012 Global EMS Aerospace and Defense (A&D) Company of the Year Award.
Sign-up for Celestica Receives Frost & Sullivan's 2012 Global EMS Aerospace and Defense Company of the Year Award investment picks
2013/3/25
TORONTO , March 25, 2013 /PRNewswire/ - Celestica Inc. (NYSE: CLS) (TSX: CLS) , a global leader in the delivery of end-to-end product lifecycle solutions, today announced it has received Frost & Sullivan's 2012 Global EMS Aerospace and Defense (A&D) Company of the Year Award.
Sign-up for Celestica Receives Frost & Sullivan's 2012 Global EMS Aerospace and Defense Company of the Year Award investment picks
2013/2/25
CHARLOTTE, N.C., Feb.
Sign-up for Celgard Files Patent Infringement Lawsuit investment picks
2013/4/25
Celgene Corp.'s (CELG) first-quarter profit fell 4.1% as the drug maker saw higher expenses offset stronger revenue from its Revlimid and Vidaza drugs.
Sign-up for Celgene 1st-Quarter Net Down 4.1% Amid Increased Costs investment picks
2013/2/20
Celgene Corporation (NASDAQ: CELG) announced today that it has entered into an accelerated share repurchase (ASR) agreement with an investment bank to repurchase an aggregate of $600 million of the company’s common stock.
Sign-up for Celgene Announces $600 Million Accelerated Share Repurchase Program investment picks
2013/4/3
Celgene Corporation (NASDAQ: CELG) senior management will host a conference call and live audio webcast on Thursday, April 25, 2013 at 9 a.m. ET to discuss the company’s first quarter 2013 financial and operational results.
Sign-up for Celgene Corporation to Announce First Quarter 2013 Results on April 25, 2013 investment picks
2013/2/28
Celgene Corporation (NASDAQ: CELG) plans to present at two upcoming investor conferences.
Sign-up for Celgene Corporation to Webcast at Two Upcoming Investor Conferences and the American Academy of Dermatology Annual Meeting investment picks
2013/2/4
Celgene Corporation (NASDAQ: CELG) plans to present at three upcoming investor conferences.
Sign-up for Celgene Corporation to Webcast at Upcoming Investor Conferences investment picks
2013/4/29
Celgene Corporation (NASDAQ: CELG) plans to present at four upcoming investor conferences in May.
Sign-up for Celgene Corporation to Webcast at Upcoming Investor Conferences and Analyst Day investment picks
2013/2/11
Celgene International Sàrl, a subsidiary of Celgene Corporation (NASDAQ: CELG), today announced that REVLIMID ® (lenalidomide) has been granted full approval, which includes an Import Drug License (IDL) by the China State Food and Drug Administration (SFDA) for use in combination with dexamethasone as a treatment for patients with relapsed or refractory multiple myeloma who have received at least one prior therapy.
Sign-up for Celgene Provides REVLIMID® Regulatory Update investment picks
2013/4/25
Celgene Corporation (NASDAQ: CELG) reported net product sales of $1,429 million for the first quarter of 2013, a 15 percent increase from the same period in 2012.
Sign-up for Celgene Reports First Quarter 2013 Operating and Financial Results investment picks
2013/1/31
First Planned Interim Survival Analysis Passes Futility Boundary SEATTLE , Jan.
Sign-up for Cell Therapeutics Announces Data Safety and Monitoring Board Recommendation to Continue the GOG-0212 Phase 3 Clinical Trial of OPAXIOTM as Maintenance Therapy in Ovarian Cancer investment picks
2013/5/2
- Conference call scheduled today at 4:30 p.m. Eastern time - SEATTLE , May 2, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2013 .
Sign-up for Cell Therapeutics Reports First Quarter 2013 Financial Results investment picks
2013/2/28
- Conference call scheduled today at 4:30 p.m. Eastern time - SEATTLE , Feb.
Sign-up for Cell Therapeutics Reports Fourth Quarter and Full Year 2012 Financial Results investment picks
2013/3/28
SEATTLE , March 28, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today it has entered into a loan agreement with Hercules Technology Growth Capital, Inc. (NYSE: HTGC) providing for a senior secured term loan of up to $15 million .
Sign-up for Cell Therapeutics Secures $15 Million Loan Financing Agreement investment picks
2013/3/11
SEATTLE , March 11, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today announced that management will present at the ROTH Capital Partners 25 th Annual Growth Stock Conference on Monday, March 18 , at 2:30 p.m. Pacific/ 5:30 p.m. Eastern/ 10:30 p.m. Central European time at the Ritz-Carlton Laguna Niguel in Dana Point, CA.
Sign-up for Cell Therapeutics to Present at the ROTH Capital Partners 25th Annual Growth Stock Conference investment picks
2013/4/24
- Conference call and webcast at 4:30 p.m. Eastern Time - SEATTLE , April 24, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) announced today that it will report its first quarter financial results on Thursday, May 2, 2013 , after the close of the U.S. financial markets.
Sign-up for Cell Therapeutics to Report First Quarter Financial Results after Market on May 2, 2013 investment picks
2013/2/26
- Conference call and webcast at 4:30 p.m. Eastern Time - SEATTLE , Feb.
Sign-up for Cell Therapeutics to Report Fourth Quarter and Full Year 2012 Financial Results After Market on February 28, 2013 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Celebrity Cruises Steps Up To The Plate As Official Cruise Line Of The Boston Red Sox to Cell Therapeutics to Report Fourth Quarter and Full Year 2012 Financial Results After Market on February 28, 2013
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity